New paper lays out problems of developing gene-edited GM crops
By Claire Robinson,
GM Watch
| 08. 30. 2023
Announcing the passing into law of the Genetic Technology Act, which removes regulatory safeguards around a whole subclass of GMOs, notably those produced using gene editing, the Westminster government breathlessly enthused that the UK had now joined “Argentina, the US, Australia and Japan”, which “have already enacted similar legislation, driving innovation on a global scale and helping fight the greatest challenges facing the world”.
I can’t pretend that GMWatch was waiting with bated breath for the “new GM”-based “innovation on a global scale” that was supposed to be pouring out of these countries, especially given the dismal performance and fate of the handful of gene-edited crops that they've released.
But the history of GM crops has settled into a pattern of hyped reports of supposed successes continuing for a good few years before they give way to sad tales of technology failure. So at this early stage of the “new GM” journey, we were expecting something reasonably upbeat about gene-edited GM crops from these deregulatory pioneering countries.
What we didn’t expect just yet is the catalogue of abject failure...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...